Importantly, our present study detected TCF3 upregulation in basal-like tumours in several additional public datasets and associated to poor survival (Figure 5C), reinforcing previous observations indicating that basal-like carcinomas are the most likely candidate breast tumours to suffer EMT processes [57]-[59]. The gene discussed is TCF3; the disease is neoplasm.